Single-Sample Confirmatory Diagnosis of Diabetes Tops AJPB Week in Review


Top news of the week from The American Journal of Pharmacy Benefits.

5. Migraine Affects Health Care Costs and Lost Productivity in Employed US Adults

Employers that offer healthcare benefits, paid sick days, and disability insurance benefits will spend about $84,000 in annual migraine-related costs for every 1000 employees. Read more.

4. Updated Secukinumab Label to Include Evidence for Treatment of Psoriatic Arthritis

The updated label includes new evidence that the treatment significantly impedes the progression of joint structural damage at 24 weeks compared to placebo for patients with active psoriatic arthritis. Read more.

3. Patients with Advanced COPD Less Likely to Receive Palliative Care

Even though patients with advanced chronic obstructive pulmonary disease (COPD) can suffer from the same distressing symptoms as those with end-stage cancer, they are less likely to receive palliative care than those with other terminal illnesses. Read more.

2. New Rare Disease Program Offers Support Service, Guidance for Patients

Patients with rare diseases often face a difficult and long diagnosis and treatment process. Read more.

1. Single-Sample Testing May Confirm Diabetes Diagnosis

While normally a diabetes diagnosis requires multiple sample confirmations from blood work of elevated hemoglobin A1C (HbA1C) or glucose, new data has shown that a single-sample confirmatory diagnosis of diabetes may be possible. Read more.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, an expert on RSV
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, an expert on RSV
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
1 KOL is featured in this program
Image credit:  Gorodenkoff |
Carrie Koenigsfeld, PharmD, FAPhA, an expert on RSV vaccination
© 2024 MJH Life Sciences

All rights reserved.